1728-24-1 Usage
General Description
1,4-Dioxaspiro[4.6]undec-6-ene is a chemical compound with the molecular formula C11H16O2. It is a bicyclic dioxaspiro compound that is commonly used in the formulation of fragrances and as a chemical intermediate in the production of various other compounds. It has a spiro ring structure, which gives it unique chemical and physical properties. 1,4-Dioxaspiro[4.6]undec-6-ene is typically synthesized through organic chemical reactions and is known for its pleasant odor and stability. It is important to handle 1,4-Dioxaspiro[4.6]undec-6-ene with caution, as it may have potential health hazards if not used and stored properly.
Check Digit Verification of cas no
The CAS Registry Mumber 1728-24-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,2 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1728-24:
(6*1)+(5*7)+(4*2)+(3*8)+(2*2)+(1*4)=81
81 % 10 = 1
So 1728-24-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H14O2/c1-2-4-6-9(5-3-1)10-7-8-11-9/h3,5H,1-2,4,6-8H2
1728-24-1Relevant articles and documents
CERTAIN FUSED PYRROLECARBOXAMIDES A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS
-
, (2008/06/13)
Disclosed are compounds of formula I: STR1 wherein R 8 and R. sub.9 independently represent hydrogen or organic substituents; W represents optionally substituted thiazolyl or quinoxalinyl; X is hydrogen, hydroxy or lower alkyl; andT is hydrogen, halogen, hydroxy, nitro, amino or alkyl,which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptor. These compounds are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.
Synthetic studies on the 1-hydroxy nortropane system: An approach to Calystegines.
Ducrot, P.-H.,Beauhaire, J.,Lallemand, J. Y.
, p. 3883 - 3886 (2007/10/02)
A general synthetic strategy for 1-hydroxy nortropane skeleton, the common feature of calystegines is described.